- Home
- CELH vs QGEN Comparison
CELH vs QGEN Comparison
Compare CELH & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELH
- QGEN
- Stock Information
- Founded
- CELH 2004
- QGEN 1986
- Country
- CELH United States
- QGEN Netherlands
- Employees
- CELH N/A
- QGEN N/A
- Industry
- CELH Beverages (Production/Distribution)
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CELH Consumer Staples
- QGEN Health Care
- Exchange
- CELH Nasdaq
- QGEN Nasdaq
- Market Cap
- CELH 8.9B
- QGEN 9.9B
- IPO Year
- CELH N/A
- QGEN 1996
- Fundamental
- Price
- CELH $34.54
- QGEN $46.05
- Analyst Decision
- CELH Strong Buy
- QGEN Buy
- Analyst Count
- CELH 16
- QGEN 9
- Target Price
- CELH $58.60
- QGEN $50.07
- AVG Volume (30 Days)
- CELH 5.4M
- QGEN 1.4M
- Earning Date
- CELH 11-05-2024
- QGEN 10-28-2024
- Dividend Yield
- CELH N/A
- QGEN 2.85%
- EPS Growth
- CELH N/A
- QGEN N/A
- EPS
- CELH 1.02
- QGEN 0.33
- Revenue
- CELH $1,489,877,000.00
- QGEN $1,940,199,000.00
- Revenue This Year
- CELH $17.90
- QGEN $2.68
- Revenue Next Year
- CELH $18.34
- QGEN $6.10
- P/E Ratio
- CELH $33.09
- QGEN $142.28
- Revenue Growth
- CELH 56.50
- QGEN N/A
- 52 Week Low
- CELH $31.55
- QGEN $34.74
- 52 Week High
- CELH $99.62
- QGEN $47.44
- Technical
- Relative Strength Index (RSI)
- CELH 36.66
- QGEN 55.96
- Support Level
- CELH $32.04
- QGEN $45.25
- Resistance Level
- CELH $34.10
- QGEN $46.04
- Average True Range (ATR)
- CELH 1.75
- QGEN 0.71
- MACD
- CELH 0.16
- QGEN -0.05
- Stochastic Oscillator
- CELH 27.86
- QGEN 82.25
About CELH Celsius Holdings Inc.
Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages (including those that are naturally caffeinated with stevia), Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius dedicates its efforts to branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).